Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:41:15.734Z.
Calculation as of: 2026-10-06T19:41:15.734Z.
Quote observation: 2026-10-06T19:38:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4d5e19f74cb926d0196b5f3ffb65db8ff8affa0edec331fa5277d4ca2ec73e8d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Decoy Therapeutics Inc.
Market Cap
$835190.00
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$827771.00
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$814420.00
Free Cash Flow Yield
N/A
TTM Avg
473.90%
3Y Avg
642.44%
5Y Avg
588.13%
Market Cap
$850879.00
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868323.00
Free Cash Flow Yield
N/A
TTM Avg
0.01%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$747565.00
Free Cash Flow Yield
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$695428.00
Free Cash Flow Yield
N/A
TTM Avg
367.33%
3Y Avg
367.33%
5Y Avg
367.33%
Market Cap
$1.02M
Free Cash Flow Yield
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $835190.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827771.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | N/A | 473.90% | 642.44% | 588.13% |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $868323.00 | N/A | 0.01% | 0.01% | 0.01% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $747565.00 | N/A | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $695428.00 | N/A | 367.33% | 367.33% | 367.33% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A | 0.00% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
